192 related articles for article (PubMed ID: 27154028)
1. Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone.
Pérez-Campo FM; Santurtún A; García-Ibarbia C; Pascual MA; Valero C; Garcés C; Sañudo C; Zarrabeitia MT; Riancho JA
Calcif Tissue Int; 2016 Sep; 99(3):302-9. PubMed ID: 27154028
[TBL] [Abstract][Full Text] [Related]
2. Methylation of bone
Shan Y; Wang L; Li G; Shen G; Zhang P; Xu Y
Biochem Cell Biol; 2019 Aug; 97(4):369-374. PubMed ID: 30257098
[TBL] [Abstract][Full Text] [Related]
3. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
Yang F; Tang W; So S; de Crombrugghe B; Zhang C
Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
[TBL] [Abstract][Full Text] [Related]
5. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts.
Vincent C; Findlay DM; Welldon KJ; Wijenayaka AR; Zheng TS; Haynes DR; Fazzalari NL; Evdokiou A; Atkins GJ
J Bone Miner Res; 2009 Aug; 24(8):1434-49. PubMed ID: 19292615
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of ENPP1 by osterix in osteoblasts and osteocytes.
Gao MM; Su QN; Liang TZ; Ma JX; Liang TZ; Stoddart MJ; Richards RG; Zhou ZY; Zou NX
Eur Cell Mater; 2018 Jul; 36():1-14. PubMed ID: 30047979
[TBL] [Abstract][Full Text] [Related]
8. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
9. Runx2-mediated regulation of the zinc finger Osterix/Sp7 gene.
Nishio Y; Dong Y; Paris M; O'Keefe RJ; Schwarz EM; Drissi H
Gene; 2006 May; 372():62-70. PubMed ID: 16574347
[TBL] [Abstract][Full Text] [Related]
10. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
11. Mitogen-activated protein kinase (MAPK)-regulated interactions between Osterix and Runx2 are critical for the transcriptional osteogenic program.
Artigas N; Ureña C; Rodríguez-Carballo E; Rosa JL; Ventura F
J Biol Chem; 2014 Sep; 289(39):27105-27117. PubMed ID: 25122769
[TBL] [Abstract][Full Text] [Related]
12. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2.
Lee MH; Kwon TG; Park HS; Wozney JM; Ryoo HM
Biochem Biophys Res Commun; 2003 Sep; 309(3):689-94. PubMed ID: 12963046
[TBL] [Abstract][Full Text] [Related]
13. Carbonate apatite increases gene expression of osterix and bone morphogenetic protein 2 in the alveolar ridge after socket grafting.
Kitazawa T; Takai H; Kono T; Okada H; Ogata Y
J Oral Sci; 2024 Jan; 66(1):15-19. PubMed ID: 38008425
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
15. Osterix induces Col1a1 gene expression through binding to Sp1 sites in the bone enhancer and proximal promoter regions.
Ortuño MJ; Susperregui AR; Artigas N; Rosa JL; Ventura F
Bone; 2013 Feb; 52(2):548-56. PubMed ID: 23159876
[TBL] [Abstract][Full Text] [Related]
16. Selective regulation of Mmp13 by 1,25(OH)
Meyer MB; Benkusky NA; Onal M; Pike JW
J Steroid Biochem Mol Biol; 2016 Nov; 164():258-264. PubMed ID: 26348136
[TBL] [Abstract][Full Text] [Related]
17. [Expression and regulation of the SOST gene].
Qin LJ; Ding DX; Cui LL; Huang QY
Yi Chuan; 2013 Aug; 35(8):939-47. PubMed ID: 23956082
[TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength.
Li X; Ominsky MS; Niu QT; Sun N; Daugherty B; D'Agostin D; Kurahara C; Gao Y; Cao J; Gong J; Asuncion F; Barrero M; Warmington K; Dwyer D; Stolina M; Morony S; Sarosi I; Kostenuik PJ; Lacey DL; Simonet WS; Ke HZ; Paszty C
J Bone Miner Res; 2008 Jun; 23(6):860-9. PubMed ID: 18269310
[TBL] [Abstract][Full Text] [Related]
19. Identification of the homeobox protein Prx1 (MHox, Prrx-1) as a regulator of osterix expression and mediator of tumor necrosis factor α action in osteoblast differentiation.
Lu X; Beck GR; Gilbert LC; Camalier CE; Bateman NW; Hood BL; Conrads TP; Kern MJ; You S; Chen H; Nanes MS
J Bone Miner Res; 2011 Jan; 26(1):209-19. PubMed ID: 20683885
[TBL] [Abstract][Full Text] [Related]
20. Sp7 and Runx2 molecular complex synergistically regulate expression of target genes.
Rashid H; Ma C; Chen H; Wang H; Hassan MQ; Sinha K; de Crombrugghe B; Javed A
Connect Tissue Res; 2014 Aug; 55 Suppl 1(0 1):83-7. PubMed ID: 25158187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
